Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Kite Pharma, Inc. (KITE)

« Back to company index

KITE Chatter Timeline

Stock Ticker for KITE

Most Active Tweeters for KITE

No tweets found

Recent Tweets for KITE

Gambiste1 @Gambiste1
RT @dhovekamp42: @ReelChuckNorris It may have not looked like that with $KITE and $NVS early CAR-T success in 2017 - overall IMO - we are…
June 10th 2019, 9:06pm
dhovekamp42 @dhovekamp42
@ReelChuckNorris It may have not looked like that with $KITE and $NVS early CAR-T success in 2017 - overall IMO -… https://t.co/3mHbfRJ46F
June 10th 2019, 9:06pm
PhotiosM @PhotiosM
@srqstockpicker Boy did $KITE make out like bandits! Now what’s the next oncology area!?
June 5th 2019, 12:06pm
egelandd @egelandd
$iova set up perfectly for a takeout: strong leadership, solid data & still relatively cheap here at 2b cap. $kite… https://t.co/2SIgFwsO83
May 22nd 2019, 5:05pm
BursatilBiotech @BursatilBiotech
King $KITE is back! ? https://t.co/I1SzS5n2Ox
May 18th 2019, 8:05am
BursatilBiotech @BursatilBiotech
#ASCO19 $KITE $GILD KITE-585, BCMA Ph1 study in MM still under embargo https://t.co/GqzMtNL0iM
May 15th 2019, 5:05pm
MLNardone @MLNardone
RT @_B_I_O_T_E_C_H_: $GILD talking allogeneic $KITE program mentiones [email protected] twice https://t.co/frKUqiGjNq
May 15th 2019, 5:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$GILD talking allogeneic $KITE program mentiones [email protected] twice https://t.co/frKUqiGjNq
May 15th 2019, 2:05pm
dhovekamp42 @dhovekamp42
RT @sesiegler: Here’s my friendly advice: if you want the $KITE CEO job, make taking it contingent upon the end of all of the #Yescarta rel…
May 3rd 2019, 6:05pm
sesiegler @sesiegler
Here’s my friendly advice: if you want the $KITE CEO job, make taking it contingent upon the end of all of the… https://t.co/FB5MgWMpKb
May 3rd 2019, 5:05pm
DewDiligence @DewDiligence
@jq1234t @bradloncar I don't buy Brad's notion that $KITE has been separated b/c cell therapy requires special "ent… https://t.co/KNVWeZlV1a
May 2nd 2019, 7:05pm
jeouwoong @jeouwoong
RT biotech_junkie: 100 pages Piper report out on CAR-T Next Generation Of Cellular Therapy $GILD $KITE Gilead/Kite: While Autologous Is I…
April 30th 2019, 7:04am
DrEnFuSt @DrEnFuSt
There is a whole lotta room here. $GILD busted it with a bloated $KITE deal. Lesson to #BigPharma , be cheap like… https://t.co/Oxg74EU58m
April 10th 2019, 11:04pm
score1more @score1more
@_don_sparrow @handcashapp I just pinged $KITE - Thank you for showing your support!
April 5th 2019, 10:04am
_don_sparrow @_don_sparrow
@score1more @handcashapp My handle is $kite.
April 5th 2019, 10:04am
DrEnFuSt @DrEnFuSt
Didn't know KITE-585 was terminated.. Time to start looking for 2nd gen Cell Therapy... And not a $KITE sized deal.… https://t.co/xOS0Vzwuv9
April 2nd 2019, 2:04pm
TheEBMT_CTIWP @TheEBMT_CTIWP
RT @cells_nnm: $KITE on dropping KITE-585 (BCMA-CAR) program: "...the treatment didn't manage strong enough results, so it was discontinued…
April 1st 2019, 5:04pm
cells_nnm @cells_nnm
$KITE on dropping KITE-585 (BCMA-CAR) program: "...the treatment didn't manage strong enough results, so it was dis… https://t.co/bvblX5RWUI
April 1st 2019, 3:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.